A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2009
10/08/2009	WO2009102894A3 Arginine-conjugated bioreducible poly (disulfide amine) polymers for gene delivery systems
10/08/2009	WO2009077874A3 A pharmaceutical composition for treating esophageal cancer
10/08/2009	WO2008118552A9 Use of ranolazine for the treatment of cardiovascular diseases
10/08/2009	US20090255004 G-Protein Coupled Receptor and Uses Therefor
10/08/2009	US20090253811 Manufacture process of organic compounds
10/08/2009	US20090253796 Method for treating vascular disease
10/08/2009	US20090253754 Fast dissolving films and coatings for controlled release of flavors, active pharmaceutical ingredients, food substances, and nicotine
10/08/2009	US20090253698 Brain, Spinal and Nerve Injury Treatment
10/08/2009	US20090253675 Pharmaceutical formulation
10/08/2009	US20090253649 Agents Containing Folic Acid, Vitamin B6 and Vitamin B12, and the Use Thereof
10/08/2009	US20090253635 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments
10/08/2009	US20090253625 GLP-1, exendin-4, peptide analogs and uses thereof
10/08/2009	US20090253175 Use to faciliate drug delivery of other drugs, or treat glycosaminoglycan associated pathologies, such as scarring, spinal cord injury, glaucoma, and cosmetic treatments
10/08/2009	US20090252805 Film-Coated and/or Granulated Calcium-Containing Compounds and Use Thereof in Pharmaceutical Compositions
10/08/2009	US20090252802 Compositions Including Relatively Water Insoluble/Unwettable Drugs And Methods For Using Same
10/08/2009	US20090252798 Matrix-gel graft without cells
10/08/2009	US20090252787 Granular pharmaceutical compositions
10/08/2009	US20090252780 Coatings for implantable medical devices
10/08/2009	US20090252762 novel proteosome-liposaccharide vaccine adjuvant
10/08/2009	US20090252743 Antibody for use in the treatment of crohn's and inflammatory diseases such as ankylosing spondylitis; human tumor necrosis factor alpha (TNF) inhibitors
10/08/2009	US20090252737 T Cell Regulatory Genes And Methods Of Use Thereof
10/08/2009	US20090252722 Botulinum Neurotoxin a Protein Receptor and Uses Thereof
10/08/2009	US20090252686 Ex Vivo Hyperpolarization of Imaging Agents
10/08/2009	CA2720359A1 Liver cancer drug
10/08/2009	CA2720343A1 Heterocyclic derivative and use thereof
10/08/2009	CA2720278A1 Agent for preventing and/or treating vascular diseases
10/08/2009	CA2720277A1 Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same
10/08/2009	CA2720049A1 Pyrimidine derivative having cell protecting effect and uses thereof
10/08/2009	CA2718310A1 Pyridyl derivatives as cftr modulators
10/07/2009	EP2107109A1 Recombinant vascular endothelial cell growth factor D (VEGF-D)
10/07/2009	EP2107070A1 Rheumatoid arthritis remedy containing IL-6 antagonist as active ingredient
10/07/2009	EP2107050A1 Lipoxin compounds
10/07/2009	EP2106807A1 Compositions and kits for enhancing delivery of therapeutic agents to cells
10/07/2009	EP2106800A1 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
10/07/2009	EP2106263A2 Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof
10/07/2009	EP1529038B1 Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
10/07/2009	EP1311249B1 Set of transdermal therapeutic systems
10/07/2009	EP1309566B1 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors
10/07/2009	EP1308441B1 2-aminopyridine compounds and use thereof as drugs
10/07/2009	EP1248774B1 Polyhydroxystilbenes and stilbene oxides as antipsoriatic agents and protein kinase inhibitors
10/07/2009	EP0861247B1 Novel imidazole n-benzyldioxol derivatives, method for preparing same, resulting intermediates, pharmaceutical compositions and use of said derivatives as endothelin antagonists
10/07/2009	CN101553243A Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
10/07/2009	CN101553231A Modulators of muscarinic receptors
10/07/2009	CN101550176A Fine purification method for cholic acid crude product
10/07/2009	CN101550114A Thiazole derivatives having CB1-antagonistic, agonistic or partial agonistic activity
10/07/2009	CN101550103A 1, 2, 3, 4-tetrahydroisoquinoline derivatives and synthetic method and uses thereof
10/07/2009	CN101548966A Application of salvianolic acid A in salvia miltiorrhiza
10/07/2009	CN100546977C New compounds for the inhibition of rotamases and use thereof
10/07/2009	CN100546655C Tablet composition containing Chinese orthodox medicine extract and process for producing the same
10/07/2009	CN100546580C Nicotin or isonicotin benzothiazole derivatives
10/06/2009	US7598418 Naphthalene-1-(sulfonamide or carboxamide) derivatives; e.g. N-Benzyl-5-{[(4-methylphenyl)sulfonyl]oxy}naphthalene-1-sulfonamide; protein kinase inhibitors sensitize cancer cells to radiotherapy or anticancer agents; side effect reduction
10/06/2009	US7598386 Sulphones which modulate the action of gamma-secretase
10/06/2009	US7598355 Characterization of GRP94-ligand interactions and purification, screening, and therapeutic methods relating thereto
10/06/2009	US7598288 Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma
10/06/2009	US7598284 Indazole compounds as B3 adrenoceptor agonist
10/06/2009	US7598277 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine
10/06/2009	US7598272 Kinase inhibitors
10/06/2009	US7598268 Vascular endothelial growth factor; tyrosine kinase inhibitor;angiogenesis inhibitor; anticarcinogenic agents
10/06/2009	US7598260 CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
10/06/2009	US7598258 Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of macrophage colony stimulating factor receptor
10/06/2009	US7598256 Pyrrolo [2,3-d] pyrimidine and their use as purinergic receptor antagonists
10/06/2009	US7598254 Substituted 1,3-thiazolo[5,4-d]pyrimidines as xanthine oxidase inhibitors
10/06/2009	US7598253 Reverse-turn mimetics and methods relating thereto
10/06/2009	US7598244 (S)-1-(3-ethoxy-1-methylpropyl)-3-[7-(3,4-methylenedioxyphenyl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]urea; preventive and/or therapeutic agent for immunological rejection and/or graft versus host reaction in organ/bone marrow transplant, autoimmune disease, allergic disease and/or inflammatory disease
10/06/2009	US7598240 Matrix metalloproteinase inhibitors; 4-[2-(hydroxyamino)-2-oxoethyl]-2-[3-(4-methoxyphenyl)propyl]-3-oxo-3,4-dihydro-2H-1,4-benzothiazine-6-carboxylic acid or its ethyl ester; chondrodegenerative diseases or inflammatory diseases such as arthrosis deformans
10/06/2009	US7598048 Administering a Prokineticin 2 receptor antagonist or agonist; control internal body clock and functions
10/06/2009	US7597905 Hollow nanoparticle for use in the transfer of biopolymer into cells
10/06/2009	CA2438622C Compositions containing creatine and creatinine
10/06/2009	CA2402431C 1,2,3,4-tetrahydroisoquinoline derivatives
10/06/2009	CA2400461C Method for improving bone modeling and chondrocyte functioning in growing canines
10/06/2009	CA2399971C Pharmaceutical composition comprising squalene epoxidase inhibitor and macrolide immunomodulator
10/06/2009	CA2376596C Humanized anti-erbb2 antibodies and treatment with anti-erbb2 antibodies
10/06/2009	CA2368095C Process for preparing inhibitors of nucleoside metabolism
10/06/2009	CA2258924C Cftr channel activator compounds and pharmaceutical compositions containing same
10/06/2009	CA2207779C Carcinoma treatment
10/06/2009	CA2180479C Method for treatment of obesity using prolactin modulators and diet
10/06/2009	CA2111205C Polypeptides having kinase activity, their preparation and use
10/01/2009	WO2009120874A2 INHIBITORS OF ANTIGEN RECEPTOR-INDUCED NF-кB ACTIVATION
10/01/2009	WO2009120648A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof
10/01/2009	WO2009119874A1 Pharmaceutical composition for treating or preventing cancer which induces dendritic cell-like differentiation of monocytes to increase anticancer immune activity
10/01/2009	WO2009119794A1 Prophylactic/therapeutic agent for infectious disease
10/01/2009	WO2009119785A1 Method for purifying ethynylthymidine compound
10/01/2009	WO2009119776A1 Fused heterocyclic derivative and use thereof
10/01/2009	WO2009119726A1 Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor
10/01/2009	WO2009119692A1 Novel glycolipid and use thereof
10/01/2009	WO2009119673A1 Transdermally absorbable preparation
10/01/2009	WO2009119672A1 COMPOSITION FOR STABILIZING β-BLOCKER, AND TRANSDERMALLY ABSORBABLE PREPARATION COMPRISING THE COMPOSITION
10/01/2009	WO2009119662A1 Peptide capable of inducing autophagic cell death
10/01/2009	WO2009119652A1 USE OF BENZOPHENONE DERIVATIVE OR SALT THEREOF AND TNF α INHIBITOR IN COMBINATION AND PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVE OR SALT THEREOF AND THE INHIBITOR
10/01/2009	WO2009119534A1 Novel tetrahydroisoquinoline derivative
10/01/2009	WO2009119528A1 Heterocyclic compound
10/01/2009	WO2009119167A1 Aniline derivative having anti-rna viral activity
10/01/2009	WO2009119092A1 Anti-tumor agent comprising cytidine derivative and carboplatin
10/01/2009	WO2009119088A1 Heterocyclic compound
10/01/2009	WO2009118753A2 Process for preparation of naratriptan hydrochloride
10/01/2009	WO2009118541A1 Modulation of fibroblast activity
10/01/2009	WO2009117938A1 A pharmaceutical composition with effect of anti-fatigue, its preparation method and its use
10/01/2009	WO2009091531A3 Uniform-sized, multi-drug carrying and photosensitive liposomes for advance drug delivery
10/01/2009	WO2009088192A3 Indole and indazole derivatives having a cell-, tissue- and organ-preserving effect
10/01/2009	WO2009085275A3 Use of anti-connexin polypeptide agent in combination with anti-connexin polynucleotide agent for the treatment of fibrotic conditions

1 ... 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 ... 1564